Transarterial chemoembolization and percutaneous ethanol injection therapy in patients with hepatocellular carcinoma

European Journal of Gastroenterology and Hepatology

Volumn 10, Issue 11, 1998, Pages 907-909

  Kirchhoff, Timm ^a   Chavan, Ajay ^a   Galanski, Michael ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Chemoembolization; Hepatocellular carcinoma; Percutaneous ethanol injection therapy; Transcatheter arterial chemoembolization

Indexed keywords

ALCOHOL;

ARTIFICIAL EMBOLISM; HUMAN; LIVER CELL CARCINOMA; PRIORITY JOURNAL; SHORT SURVEY; TUMOR VOLUME;

EID: 0031797702     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042737-199811000-00001     Document Type: Short Survey

References (57)

1. Haydon GH, Hayes PC. Screening for hepatocellular carcinoma. Eur J Gastroenterol Hepatol 1996; 8:856-860.
2. Liu CL, Sheung TF. Nonresectional therapies for hepatocellular carcinoma. Am J Surg 1997; 173:358-365.
3. Oka H, Kurioka N, Kim N, Kanno T, Kuroki T, Mizoguchi Y, et al. Prospective study of early detection of hepatocellular carcinoma in patients with cirrhosis. Hepatology 1990; 12:680-687.
4. Colombo M, De Francis R, Del Ninno E, Sangiovanni A, deFacio C, Tommasini M, et al. Hepatocellular carcinoma in Italian patients with cirrhosis. N Engl J Med 1991; 325:675-680.
5. The Liver Cancer Study Group of Japan. Primary liver cancer in Japan: clinicopathologic features and results of surgical treatment. Ann Surg 1990; 211:277-287.
6. Lai CL, Wu PC, Chan GCB, Lok AS, Lin HJ, Doxorubicin versus no antitumor therapy in inoperable hepatocellular carcinoma: a prospective, randomized trial. Cancer 1988; 62:479-483.
7. Ravry MJR, Omura GA, Bartolucii AA, Einhorn L, Kramer B, Davilla E, et al. Phase II evaluation of cisplatin in advanced hepatocellular carcinoma and cholangiocarcinoma: a Southern Cancer Study Group Trial. Cancer Treat Rep 1986; 70:311-312.
8. Falkson G, MacIntyre JM, Moertel CG, Johnson LA, Schermann RC. Primary liver cancer: an Eastern Cooperative Oncology Group Trial. Cancer 1984; 54:970-977.
9. Rasmussen I, Garden OJ. The management of liver cell cancer. Eur J Gastroenterol Hepatol 1996; 8:861-867.
10. Goldstein HM, Wallace S, Anderson JH, Bree RL, Gianturco C. Transcatheter occlusion of abdominal tumors. Radiology 1976; 120:539-545.
11. Wheeler PG, Mella W, Dubbins P, Jones B, Nunnerley H, Johnson P, Williams R. Non-operative arterial embolization in primary liver tumors. BMJ 1979, ii:242-244.
12. Chuang VP, Wallace S. Hepatic artery embolization in the treatment of hepatic neoplasms. Radiology 1981; 140:51-58.
13. Yamada R, Sato M, Kawabata M, Nakatsuka H, Nakamura K, Takashima S, et al. Hepatic artery embolization in 120 patients with unresectable hepatoma. Radiology 1983; 148:397-401.
14. Livraghi T, Festi D, Monti F, Salmi A, Vettori C. US-guided percutaneous alcohol injection of small hepatic and abdominal tumors. Radiology 1986; 161:309-312.
15. Sheu JC, Huang GT, Chen DS, Sung JL, Yang PM, Wei TC, et al. Small hepatocellular carcinoma: intratumor ethanol treatment using new needle and guidance systems. Radiology 1987; 163:43-48.
16. Shima S, Yasuda H, Muto H, Tagawa H, Unuma T, Ibukuro K, et al. Percutaneous ethanol injection in the treatment of liver neoplasms. Am J Radiol 1987; 149:949-952.
17. Livraghi T, Salmi A, Bolondi L, Marin G, Arient V, Monti F, Vettori C, Small hepatocellular carcinoma: percutaneous alcohol injection - results in 23 patients. Radiology 1988; 168:313-317.
18. Cuschieri A, Crosthwaite G, Shimi S, Pietrabissa A, Joypaul V, Tair I, et al. Hepatic cryotherapy for liver tumors. Development and clinical evaluation of a high-efficiency insulated multineedle probe system for open and laparoscopic use. Surg Endosc 1995; 9:483-489.
19. Matsuzaki Y, Osuga T, Saito Y, Chuganji Y, Tanaka N, Shoda J, et al. A new, effective, and save therapeutic option using proton irradiation for hepatocellular carcinoma. Gastroenterology 1994; 106:1032-1041
20. Houle S, Yip TK, Shepherd FA, Rotstein LE, Sniderman KW, Theis E, et al Hepatocellular carcinoma: pilot trial of treatment with Y-90 microspheres. Radiology 1989; 172:857-860.
21. Engstrom PF, Levin B, Moertel CG, Schutt A. A phase II trial of tamoxifen in hepatocellular carcinoma. Cancer 1990; 65:2641-2643.
22. Sachs E, Di Bisceglie AM, Dusheiko GM, Song E, Lyons SF, Schoub BD, et al. Treatment of hepatocellular carcinoma with recombinant leukocyte interferon: a pilot study. Br J Cancer 1985; 52:105-109.
23. Takayasu K, Moriyama N, Muramatsu Y, Suzuki M, Yamada T, Kishi K, et al. Hepatic arterial embolization for hepatocellular carcinoma: comparison of CT scans and resected specimens. Radiology 1984; 150:661-665
24. Hsu HC, Wie TC, Tsang YM, Wu MZ, Lin YH, Huang SM, et al. Histologic assessment of resected hepatocellular carcinoma after transcatheter hepatic arterial embolization Cancer 1986; 57:1184-1191.
25. Ikeda K, Kumada H, Saitoh S, Arase Y, Chayama K. Effect of repeated transcatheter arterial embolization on survival time in patients with hepatocellular carcinoma: an analysis by the Cox proportional model. Cancer 1991; 68:2150-2154.
26. Khan KN, Nakata K, Kusumoto Y, Shima M, Ishii N, Koji T, Nagataki S. Evaluation of nontumorous tissue damage by transcatheter arterial embolization for hepatocellular carcinoma. Cancer Res 1991; 51:5667-5671.
27. Shibata J, Fujiyama S, Sato T, Kishimoto S, Fukushima S, Nakano M, et al. Hepatic arterial injection chemotherapy with cisplatin suspended in an oily lymphographic agent for hepatocellular carcinoma. Cancer 1989; 64:1586-1594.
28. Stefanini GF, Amorati P, Biselli M, Mucci F, Celi A, Arienti V, et al. Efficacy of transarterial targeted treatments on survival of patients with hepatocellular carcinoma. An Italian experience. Cancer 1995; 75:2427-2434.
29. Chen C, Chen PJ, Yang PM, Huang GT, Lai MY, Tsang YM, et al. Clinical and microbiological features of liver abscess after transarterial embolization for hepatocellular carcinoma. Am J Gastroenterol 1997; 92:2257-2259.
30. Haneda T, Une Y, Kamiyama T, Shimamura T, Nakanishi K, Sakurai T, et al. Two hepatocellular carcinoma patients with biloma after transarterial embolization with lipiodol (Lip-TAE) leading to occlusion of portal vein. Gan To Kagaku Ryoho 1995; 22:1665-1668 (abstract in English, article in Japanese).
31. Ichikawa T, Yamada T, Takagi H, Abe T, Ito H, Sakurai S, et al. Transcatheter arterial embolization-induced bilious pleuritis in a patient with hepatocellular carcinoma. J Gastroenterol 1997; 32:405-409.
32. Livraghi T, Bolondi L, Lazzaroni S, Marin G, Morabito A, Rapacini GL, et al. Percutaneous ethanol injection in the treatment of hepatocellular carcinoma in cirrhosis. Cancer 1992; 69:925-929.
33. Shiina S, Tagawa K, Niwa Y, Unuha T, Komatsu Y, Yoshiura K, et al. Percutaneous ethanol injection therapy for hepatocellular carcinoma: results in 146 patients. Am J Roentgenol 1993; 160:1023-1028.
34. Castells A, Bruix J, Bru C, Fuster J, Vilana R, Navasa M, et al. Treatment of small hepatocellular carcinoma in cirrhotic patients: a cohort study comparing surgical resection and percutaneous ethanol injection. Hepatology 1993; 18:1121-1126.
35. Kotoh K, Sakai H, Sakamoto S, Nakayama S, Satoh M, Morotomi I, Nawata I. The effect of percutaneous ethanol injection on small hepatocellular carcinoma is comparable to that of hepatectomy. Am J Gastroenterol 1994; 89:194-198.
36. Redvanly RD, Chezmar JL, Strauss RM, Galloway JR, Boyer TD, Bernadino ME. Malignant hepatic tumors: safety of high-dose percutaneous ethanol ablation therapy. Radiology 1993; 188:283-285.
37. Ishii H, Okada S, Nose H, Okusaka T, Yoshimori M, Takayama T, et al. Local recurrence of hepatocellular carcinoma after percutaneous ethanol injection. Cancer 1996; 77:1792-1796.
38. Livraghi T, Giorgio A, Marin G, Salmi A, deSio I, Bolondi L, et al. Hepatocellular carcinoma and cirrhosis in 746 patients: longterm results of percutaneous ethanol injection. Radiology 1995; 197:101-108.
39. Isobe H, Fukai T, Iwamoto H, Satoh M, Tokumatsu M, Sakai H, et al. Liver abscess complicating intratumoral injection therapy for HCC. Am J Gastroenterol 1990; 85:1646-1648.
40. DiStasi M, Buscarini L, Livraghi T, Giorgio A, Salmi A, deSio I, et al. Percutaneous ethanol injection in the treatment of hepatocellular carcinoma. A multicenter survey of evaluation practices and complication rates. Scand J Gastroenterol 1997; 32:11 68-1173.
41. Koda M, Okamoto M, Miyoshi Y, Kawasaki H. Hepatic vascular and bile duct injury after ethanol injection therapy for hepatocellular carcinoma. Gastrointest Radiol 1992; 17:167-169.
42. Taavitsainen M, Vehmas T, Kauppila R. Fatal liver necrosis following ethanol injection for hepatocellular carcinoma. Abdom Imaging 1993; 18:357-359.
43. Cedrone A, Rapaccini GL, Pompili M, Grattagliano A, Aliotta A, Trombino C. Neoplastic seeding complicating percutaneous ethanol injection for treatment of hepatocellular carcinoma. Radiology 1992; 183:787-788.
44. Shiina S, Tagawa K, Unuma T, Fujino H, Uta Y, Niwa Y. Percutaneous ethanol injection therapy of hepatocellular carcinoma. Analysis of 77 patients. Am J Radiol 1990; 155:1221-1226.
45. Vilana R, Bruix J, Bru C, Ayuso C, Sole M, Rodes J, et al. Tumor size determines the efficacy of percutaneous ethanol injection for the treatment of small hepatocellular carcinoma. Hepatology 1992; 16:353-357.
46. Shiina S, Tagawa K, Unuma T, Takanashi R, Yoshiura R, Komatsu Y, et al. Percutaneous ethanol injection therapy for hepatocellular carcinoma: a histopathologic study. Cancer 1991; 68:1524-1530.
47. Tanaka K, Okazaki H, Nakamura S, Endo O, Inoue S, Takamura Y, et al. Hepatocellular carcinoma: treatment with a combination therapy of transcatheter arterial embolization and percutaneous ethanol injection. Radiology 1991; 179:713-717.
48. Higuchi T, Kikuchi M, Okazaki M. Hepatocellular carcinoma after transcatheter hepatic arterial embolization: a histopathologic study of 84 resected cases. Cancer 1994; 73:2259-2267.
49. Bartolozzi C, Lencioni R, Caramella D, Vignali C, Ciorti R, Mazzeo S, et al. Treatment of large HCC: transcatheter arterial chemoembolization combined with percutaneous ethanol injection versus repeated transcatheter arterial chemoembolization. Radiology 1995; 197:812-818.
50. Hasuike Y, Okamura J, Furukawa J, Naomi M, Takata N, Maruyama H, et al. Efficacy of combination treatment (TAE with adriamycin and ethanol) for hepatocellular carcinoma. Cancer Chemother Pharmacol 1992: 31(suppl):30-34.
51. Lencioni R, Vignali C, Caramella D, Cioni R, Mazzeo S, Bartolozzi C, et al. Transcatheter arterial embolization followed by percutaneous ethanol injection in the treatment of hepatocellular carcinoma. Cardiovasc Intervent Radiol 1994; 17:70-75.
52. Koda M, Okamoto K, Miyoshi Y, Kato S, Murawaki Y, Hone Y, et al. Combination therapy with transcatheter arterial embolization and percutaneous ethanol injection for advanced hepatocellular carcinoma. Hepatogastroenterology 1994; 41:25-29.
53. Tanaka K, Nakamura S, Numata K, Kondo M, Morita K, Kitamura T, et al. The long term efficacy of combined transcatheter arterial embolization and percutaneous ethanol injection in the treatment of patients with large hepatocellular carcinoma and cirrhosis. Cancer 1998; 82:78-85.
54. Vehmas T, Taari K, Kivisaari L, Laurila P, Taavitsainen M. Intra- and perihepatic effects of ethanol injections in the pig liver. Scand J Gastroenterol 1993; 28:791-794.
55. Numata K, Tanaka K, Kiba T, Saito S, Morita K, Kitamura T, et al. SMANCS-TAE combined with PEI in the treatment for hepatocellular carcinoma. Gan To Kagaku Ryoho 1998; 25(suppl 1):141-145 (abstract in English, article in Japanese).
56. Yoshikawa M, Ebara M, Fukuda H, Sugiura N, Saisho H. Repeated arterial infusion of zinostatin stimalamer using port for advanced hepatocellular carcinoma. Gan To Kagaku Ryoho 1998; 25(suppl 1):30-33 (abstract in English, article in Japanese).
57. Saegusa M, Takano Y, Okudaira M. Human hepatic infarction: histopathological and postmortem angiological studies. Liver 1993; 13:239-245.